NPSP

(MM)
45.99
0.00 (0.00%)

NPS Pharmaceuticals Inc. (NPSP) Fundamentals

SHARE INFORMATION
Market Cap$ 4,991,475,695
Shares Outstanding108,581,155
Float108,581,155
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 224,062,000
Latest Fiscal EPS$ -0.08
Latest Fiscal Date2014-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions321
Institutional Holdings Date2015-01-31
Institutional Bought Previous 3 Months20,349,972
Institutional Holdings Percent92.0%
Institutional Sold Previous 3 Months13,342,089
Insider Holdings Date2015-01-31
Insider Bought Previous 3 Months178,949
Insider Holdings Percent1.4
Insider Sold Previous 3 Months196,637
Insider Shares Owned-
TRADING INFO
52 Week High$ 46.01
52 Week Low$ 22.11
52 Week High Change$ 31.42
21 Day Moving Average$ 45.9114
21 Day Extended Moving Average$ 45.5624
50 Day Moving Average$ 43.1466
50 Day Extended Moving Average$ 42.7766
200 Day Moving Average$ 32.7787
200 Day Extended Moving Average$ 34.6357
10 Day Average Volume1,829,724
20 Day Average Volume2,964,375
30 Day Average Volume4,001,401
50 Day Average Volume5,181,241
Alpha0.044983
Beta0.3973
Standard Deviation0.154380
R20.009368
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.120003
21 Day Percent Change0.26%
30 Day Price Change$ 0.100002
30 Day Percent Change0.22%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 10.20
Quarter to Date Percent Change28.52%
180 Day Price Change$ 16.55
180 Day Percent Change56.25%
200 Day Price Change$ 18.80
200 Day Percent Change69.19%
Year to Date Price Change$ 10.20
Year to Date Percent Change28.52%

NPS Pharmaceuticals Inc. (NPSP) Key Ratios

PROFITABILITY
EBIT Margin2.6%
EBITDA Margin4.1%
Pre-Tax Profit Margin-15.2%
Profit Margin Count-3.89%
Gross Margin93.5%
Profit Margin TOT-3.89%
INCOME STATEMENTS
Revenue$ 224,062,000
Revenue Per Share$ 2.0635
Revenue (3 Years)$ 29.00
Revenue (5 Years)$ 21.88
FINANCIAL STRENGTH
Price to Tangible Book46.70
Total Debt To Equity0.80
Int Coverage0.40
Current Ratio4.60
Leverage Ratio2.30
Quick Ratio3.80
Long Term Debt To Capital0.40
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 0.00
Price to Sales22.2772
Price to Free Cash-252.10
PE High Last 5 Years0.00
Price To Book37.30
Price To Cash Flow-2,306.60
PE Low Last 5 Years0.00
Price to Tangible Book46.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.00
Invoice Turnover0.40
Assets Turnover0.80
Return Assets-2.99
Return on Equity-7.29
Return on Capital-3.89

NPS Pharmaceuticals Inc. (NPSP) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOFrancois Nader
Emplyoees365
Last AuditUQ
CIK0000890465
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address550 Hills Drive, 3rd Floor
Bedminster, NJ 7921
Websitehttp://www.npsp.com
Facsimile+1 908 450-5351
Telephone+1 908 450-5300
Email-


Your Recent History
NASDAQ
NPSP
Nps
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.